LAMATTINA JOHN L Insider Trades

Insider Trading History

Track insider trading activity for LAMATTINA JOHN L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.27M 31,303 shares
Last Trade
Jun 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.15M 4,591 shares
$250.88
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.35M 31,560 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$894k 3,774 shares
$237.00
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $0 0 shares
Last Trade
Mar 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$436k 2,161 shares
$201.90
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.74M 32,885 shares
Last Trade
Mar 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$436k 2,161 shares
$201.90
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.1M 30,724 shares
Last Trade
Mar 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$434k 2,161 shares
$200.76
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $0 0 shares
Last Trade
Nov 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$412k 2,034 shares
$202.48
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.1M 30,724 shares
Last Trade
Nov 07, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$418k 2,034 shares
$205.45
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.74M 32,869 shares
Last Trade
Nov 07, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$434k 2,145 shares
$202.48
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.7M 32,758 shares
Last Trade
Nov 07, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$412k 2,034 shares
$202.48
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $0 0 shares
Last Trade
Nov 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$434k 2,145 shares
$202.48
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.1M 30,724 shares
Last Trade
Jun 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$613k 5,783 shares
$105.99
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $0 0 shares
Last Trade
Nov 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$295k 2,406 shares
$122.55
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $8.74M 29,515 shares
Last Trade
Nov 27, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$298k 2,406 shares
$123.65
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $9.46M 31,921 shares
Last Trade
Nov 27, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$295k 2,406 shares
$122.55
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $8.74M 29,515 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$436k 5,444 shares
$80.06
$296.26
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $8.37M 28,263 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 5,461 shares
$73.76
$296.26
Immunome
Immunome IMNM
Director
Holding Value $149k 6,500 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.5k 6,500 shares
$4.84
$22.92
Immunome
Immunome IMNM
Director
Holding Value $1.53M 66,953 shares
Last Trade
Jan 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.5k 15,125 shares
$4.00
$22.92
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $1.33M 4,484 shares
Last Trade
Dec 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$301k 4,484 shares
$67.03
$296.26
Immunome
Immunome IMNM
Director
Holding Value $149k 6,500 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17k 6,500 shares
$2.62
$22.92

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up